Iterum Therapeutics plc

Ownership Transactions Reported by 9 Insiders

Symbol
ITRM on Nasdaq
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland

Insiders trading volume in the past year

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Corey N. Fishman Chief Executive Officer, Director $299 K +$15.9 K +5.6% Nov 20, 2023
Michael W. Dunne Director $159 K +$94.1 K +145% Dec 22, 2023
Ronald Hunt Director $156 K Oct 1, 2023
Judith M. Matthews Chief Financial Officer $92.4 K Mar 31, 2023
Sailaja Puttagunta Chief Medical Officer $75.3 K Dec 1, 2023
David G. Kelly Director $52.4 K Jun 15, 2022
Beth Hecht Director $26.4 K Jun 15, 2023
Mark Chin Director $25.6 K Jun 15, 2023
Brenton K. Ahrens Director $24.2 K Dec 23, 2022

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership